Common Krait venom neurotoxins

Common Krait venom neurotoxins are a potent group of toxic proteins found in the venom of the Common Krait (Bungarus caeruleus), primarily responsible for the severe neurotoxicity observed in envenomation victims (StatPearls, NBK431063). The most significant components are the presynaptic beta-bungarotoxins and the postsynaptic alpha-neurotoxins (UniProt, P00617). Beta-bungarotoxins function through their phospholipase A2 activity, which causes an initial surge of acetylcholine release followed by the total depletion of synaptic vesicles and structural damage to the motor nerve terminals (PubMed, 21570211). This presynaptic damage is often irreversible, leading to prolonged paralysis that may not respond well to antivenom if treatment is delayed. Alpha-neurotoxins act postsynaptically by binding with high affinity to nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction, blocking the action of acetylcholine and causing flaccid paralysis (PubChem, CID 16132301). Clinically, these toxins lead to progressive muscular weakness, ptosis, and life-threatening respiratory failure (WHO, Snakebite Envenoming). Management involves the administration of polyvalent antivenom to neutralize circulating toxins, though mechanical ventilation is frequently required due to the potency and mechanism of the neurotoxins (StatPearls, NBK559134).

Other names

Bungarus caeruleus neurotoxinsKrait venom toxinsBeta-bungarotoxinAlpha-bungarotoxinBungarotoxins

Antivenom antibodies bind to and neutralize circulating toxins, preventing their interaction with presynaptic and postsynaptic targets; acetylcholinesterase inhibitors like neostigmine may be used to temporarily increase acetylcholine levels at the synapse (WHO, Snakebite Envenoming; StatPearls, NBK559134).